The Peptide Observer

Peptide research, explained for people who are not scientists.

Quick answer

What is Triptorelin?

Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk. No qualified clinical reviewer. How this site works

Triptorelin is a peptide, grouped on this site under Endocrine and immune signalling peptides, and the 12 research records kept here are 12 from trials in people.

The literature search returned 1,047 records. This site keeps 12 of them, which is 1.1 per cent of what came back.

What it is

This site puts it in the Endocrine and immune signalling peptides group.

A gonadotropin-releasing hormone agonist; the retrieved records report ovarian and testicular suppression after sustained administration and ovulation triggering after a single bolus.[1, 2]

Stated in the titles of the cited 2011 JAMA and 2000 Human Reproduction papers.

What kind of records

Several of the records kept here are trials in people.

That sentence is produced by counting, not by reading. What was counted: 12 of 12 indexed records are interventional human trials by their own assigned publication type.

What this does not settle

Where this comes from

The records cited above, in full.

  1. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA (2011). pmid:21771987
  2. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Human reproduction (Oxford, England) (2000). pmid:10966996